Gehan A. Hegazy

679 total citations
31 papers, 500 citations indexed

About

Gehan A. Hegazy is a scholar working on Molecular Biology, Epidemiology and Rheumatology. According to data from OpenAlex, Gehan A. Hegazy has authored 31 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Gehan A. Hegazy's work include Bioactive Compounds and Antitumor Agents (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Liver Disease and Transplantation (3 papers). Gehan A. Hegazy is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Liver Disease and Transplantation (3 papers). Gehan A. Hegazy collaborates with scholars based in Saudi Arabia, Egypt and United Arab Emirates. Gehan A. Hegazy's co-authors include Hesham N. Mustafa, Sally A. El Awdan, Ahmed M. Al‐Abd, Aliaa A. Alamoudi, Abdulwahab Noorwali, Hani Choudhry, Gehad A. Abdel Jaleel, Olfat Shaker, Marawan A. Elbaset and Ghada Ajabnoor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Gehan A. Hegazy

28 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gehan A. Hegazy Saudi Arabia 11 140 85 70 63 62 31 500
Soha Osama Hassanin Egypt 16 214 1.5× 57 0.7× 68 1.0× 57 0.9× 40 0.6× 25 622
Jin‐Zi Ji China 12 181 1.3× 131 1.5× 111 1.6× 36 0.6× 46 0.7× 27 534
Shu‐Yi Yin Taiwan 9 220 1.6× 88 1.0× 65 0.9× 22 0.3× 25 0.4× 15 573
Nagaraj M. Kulkarni India 13 151 1.1× 47 0.6× 32 0.5× 86 1.4× 43 0.7× 19 410
Prasanna Rajagopalan Saudi Arabia 17 232 1.7× 141 1.7× 84 1.2× 23 0.4× 36 0.6× 54 663
Qunyi Li China 19 478 3.4× 58 0.7× 55 0.8× 69 1.1× 52 0.8× 54 829
Rehab Kamel Egypt 15 197 1.4× 54 0.6× 69 1.0× 38 0.6× 26 0.4× 30 703
Liwei Gu China 18 348 2.5× 100 1.2× 104 1.5× 58 0.9× 27 0.4× 46 747
Rong Pan China 16 332 2.4× 153 1.8× 102 1.5× 34 0.5× 45 0.7× 33 674
Shuang Ren China 13 364 2.6× 112 1.3× 131 1.9× 104 1.7× 41 0.7× 32 757

Countries citing papers authored by Gehan A. Hegazy

Since Specialization
Citations

This map shows the geographic impact of Gehan A. Hegazy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gehan A. Hegazy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gehan A. Hegazy more than expected).

Fields of papers citing papers by Gehan A. Hegazy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gehan A. Hegazy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gehan A. Hegazy. The network helps show where Gehan A. Hegazy may publish in the future.

Co-authorship network of co-authors of Gehan A. Hegazy

This figure shows the co-authorship network connecting the top 25 collaborators of Gehan A. Hegazy. A scholar is included among the top collaborators of Gehan A. Hegazy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gehan A. Hegazy. Gehan A. Hegazy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hegazy, Gehan A., et al.. (2025). Expression of lncRNA NEAT1, miR-21, and IL17 in Rheumatoid Arthritis Patients. Biologics. Volume 19. 201–211.
2.
Hegazy, Gehan A., et al.. (2025). Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine. Lipids in Health and Disease. 24(1). 182–182. 1 indexed citations
4.
Hegazy, Gehan A., et al.. (2023). Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices. Biologics. Volume 17. 1–9. 5 indexed citations
6.
Khouzam, Raefa Abou, Gehan A. Hegazy, Aliaa A. Alamoudi, et al.. (2021). Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells. Biomedicine & Pharmacotherapy. 140. 111730–111730. 9 indexed citations
7.
Hegazy, Gehan A., et al.. (2020). Diet influences levels of plasma lipopolysaccharide (LPS) and its soluble receptor (sCD14) in Saudis. Journal of the Pakistan Medical Association. 70(0). 1–1. 1 indexed citations
10.
Alamoudi, Aliaa A., et al.. (2018). Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities. Scientific Reports. 8(1). 11674–11674. 122 indexed citations
11.
Alamoudi, Aliaa A., et al.. (2018). Abstract 5813: Thymoquinone influences the anticancer properties of paclitaxel and gemcitabine against breast cancer cells. Cancer Research. 78(13_Supplement). 5813–5813. 3 indexed citations
12.
Kandeel, Wafaa A., et al.. (2018). Serum neutrophil gelatinase-associated lipocalin in obese adolescents. SHILAP Revista de lepidopterología. 42(1). 2 indexed citations
13.
Shaker, Olfat, et al.. (2017). A novel mutation in exon 1 of GATA4 in Egyptian patients with congenital heart disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(1). 217–221. 4 indexed citations
14.
Mustafa, Hesham N., Gehan A. Hegazy, Sally A. El Awdan, & Marawan A. Elbaset. (2017). Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity. Tissue and Cell. 49(3). 410–426. 45 indexed citations
15.
Gad, Hoda, et al.. (2016). The association of vaspin rs2236242 and leptin rs7799039 polymorphism with metabolic syndrome in Egyptian women. TURKISH JOURNAL OF MEDICAL SCIENCES. 46(5). 1335–1340. 25 indexed citations
16.
Mustafa, Hesham N., et al.. (2015). The ameliorative potential of Hyphaene thebaica on streptozotocin-induced diabetic nephropathy. Folia Morphologica. 74(4). 447–457. 13 indexed citations
17.
Mustafa, Hesham N., Sally A. El Awdan, Gehan A. Hegazy, & Gehad A. Abdel Jaleel. (2015). Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-induced toxicity in rats: Biochemical and immunohistochemical study. Indian Journal of Pharmacology. 47(6). 649–649. 57 indexed citations
18.
Almutairi, Maha S., Gehan A. Hegazy, Mogedda E. Haiba, et al.. (2014). Synthesis, Docking and Biological Activities of Novel Hybrids Celecoxib and Anthraquinone Analogs as Potent Cytotoxic Agents. International Journal of Molecular Sciences. 15(12). 22580–22603. 12 indexed citations
20.
Mustafa, Hesham N., Sally A. El Awdan, & Gehan A. Hegazy. (2013). Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: Biochemical and Ultrastructural study. Tissue and Cell. 45(5). 350–362. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026